EN DE

Zevia PBC (ZVIA) Fair Value & Analysis

Consumer Defensive · US · Market cap $107M

ZP Zevia PBC logo Zevia PBC ZVIA · US
Price$1.44
Fair Value$0.2975
Upside-79.3%
Quality47/100
Watch Zevia PBC for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Loss-making · -4.1% net margin
negative free cash flow
Trails peers (3/9)
Narrow moat 11/100
Evidence: Low Range $0.1785 – $0.3825 Share as image

Fair value as of: Jul 25, 2026

From 3 valuation models · updated 16 days ago

Share price −15.3% over the past month.

Below-average quality, and screening another 79% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case ($0.3825). The favourable scenario is already priced in.
  • The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
  • Solid but not exceptional quality (47/100) and above fair value, neither a clear bargain nor a standout compounder.
  • A fairly wide model range ($0.1785 to $0.3825) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$16.91 $0.6150 Fair Value $0.2975 Jul 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 25, 2026.

How to read this chart

60‑month range $0.6150 – $16.91 · fair‑value band $0.1785 – $0.3825 · the $1.44 price screens above the $0.2975 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 25, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Zevia PBC (ZVIA) currently trades at $1.44, while our model-based Fair Value estimate is $0.2975, implying the stock looks roughly 79.3% overvalued today. The Quality Score stands at 47/100 (below-average quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).

Over the trailing twelve months, Zevia PBC generated revenue of $169M at a net margin of -4.1%. Revenue grew 21.2% year over year. It earns a return on equity of -20.0%. The balance sheet holds a net cash position of $24.7M. Fundamentals as of Jul 25, 2026

Our scenario range runs from $0.1785 (bear case) to $0.3825 (bull case); at $1.44, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 61% below its 52-week high and 30% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -14% fair-value upside, at -79%, ZVIA screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Gordon GGM $0.2100 $0.3500 $0.4500 70
DDM Multi-Stage $0.2100 $0.3000 $0.3700 61
NCAV (Graham) $0.3600 $0.4800 $0.7100 50
All 3 models by family
Dividend Discount
Gordon GGM $0.2100 $0.3500 $0.4500 70
DDM Multi-Stage $0.2100 $0.3000 $0.3700 61
Asset-Based
NCAV (Graham) $0.3600 $0.4800 $0.7100 50

Widest divergence: Asset-Based ($0.4800) versus Dividend Discount ($0.3000). Highest evidence: Gordon GGM (70).

Notify me when ZVIA reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $169M
Revenue growth (YoY) +21.2%
Net margin -4.1%
Return on equity -20.0%
Free cash flow −$5.0M FY2025
Operating margin -0.3%
More key figures
EPS (TTM) $-0.1000
Net cash $24.7M FY2025

Figures from reported company fundamentals · as of Jul 25, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 47/100

Of which business quality 49 · Market factors (momentum, volatility) 22

Profitability 40
Margins and returns on capital today
Quality Growth 78
Are margins and returns improving?
Cashflow 4
Earnings quality: real cash, not paper profit
Fin. Strength 87
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 30
Calm price path (market factor)
Momentum 24
Price trend over the last 3–12 months (market factor)
52W Momentum 7
Distance to the 52-week high (market factor)
Net Issuance 0
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Zevia PBC develops, markets, sells, and distributes zero sugar beverages in the United States and Canada. The company offers soda, energy drinks, and organic tea under the Zevia brand name.

Full company description

Zevia PBC develops, markets, sells, and distributes zero sugar beverages in the United States and Canada. The company offers soda, energy drinks, and organic tea under the Zevia brand name. It serves grocery distributors; national, convenience, natural products, and warehouse club retailers; and retailers through a network of grocery, drug, warehouse club, mass, natural, convenience, and e-commerce channels, as well as natural product stores and specialty outlets. The company was founded in 2007 and is headquartered in Encino, California.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Zevia PBC reported revenue of $161M in FY2025 versus $138M in FY2021, a compound +3.9%/yr. Reported net income was −$10.1M in FY2025.

Growth Quality 30/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2025)
$161M
Latest YoY
+4.0%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−0.4%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+7.9%
Avg. growth/yr (6Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+11.1%
Revenue +3.9%/yr
FY21 $138M
FY22 $163M
FY23 $166M
FY24 $155M
FY25 $161M
Net income
FY21 −$47.9M
FY22 −$33.9M
FY23 −$21.5M
FY24 −$20.0M
FY25 −$10.1M

ZVIA screens 79% overvalued. Compare with The Coca-Cola Company →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Zevia PBC Fair Value". https://www.fairvalue-calculator.com/stock/ZVIA

Peer Group

Beverages - Non-Alcoholic · 92 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 47 · Below median
Fair Value upside −79% · Bottom 25%
Return on assets -6% · Bottom 25%
Net margin (TTM) -4% · Bottom 25%
Operating margin (TTM) -0% · Bottom 25%
Revenue growth 21% · Top 25%

Valuation Multiples vs Beverages - Non-Alcoholic median · lower = cheaper

P/B 2.09× · Cheaper than median
P/S (TTM) 0.63× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 27
FUTURE 100 · sector 44
PAST 0 · sector 48
HEALTH 0 · sector 95
DIVIDEND 0 · sector 46

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Alcohol

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Beverages - Non-Alcoholic stocks, each showing price versus our Fair Value estimate (as of Jul 25, 2026).

Stock Price Fair Value vs Fair Value
The Coca-Cola Company KO $87.05 $36.57 -58%
PepsiCo, Inc PEP $139.02 $106.91 -23%
Monster Beverage Corporation MNST $97.50 $35.82 -63%
Nongfu Spring Co 9633 HK$41.44 HK$30.72 -26%
Coca-Cola Europacific Partners PLC CCEP €92.10 €85.41 -7%
Keurig Dr Pepper Inc KDP $31.25 $30.99 -1%
Coca-Cola FEMSA, S.A. KOF $102.04 $106.45 +4%
Coca-Cola HBC AG EEE €57.90 €52.82 -9%
Varun Beverages Limited VBL ₹495.70 ₹187.49 -62%
Eastroc Beverage (Group) Co 605499 ¥124.43 ¥107.57 -14%

Compare Zevia PBC with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Zevia PBC (ZVIA) overvalued or undervalued?
As of Jul 25, 2026, our model estimates a fair value of $0.2975 versus a price of $1.44, about −79% (overvalued).
What is the fair value of ZVIA?
Our model-based fair value for Zevia PBC is $0.2975 (as of Jul 25, 2026), built from audited fundamentals. The current price is $1.44.
What is the quality score of ZVIA?
Zevia PBC has a Quality Score of 47/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Zevia PBC (ZVIA)?
Zevia PBC reported trailing-twelve-month revenue of about $169M (latest available figure, as of Jul 25, 2026).
What is the net profit margin of ZVIA?
The net profit margin of Zevia PBC is about -4.1%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Zevia PBC and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.